Exercise of options
Faron Pharmaceuticals Oy ("Faron" or the "Company") Exercise of options Issue of equity Company announcement, 13 May 2020 at 15.00 (EEST) TURKU, FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received notifications from option holders to exercise D options over 9,000 ordinary shares in the Company at an exercise price of €1.09 per share under the Company's 2015 Option Plan ("New Ordinary Shares"). The terms and conditions of the 2015 Option Plan are available on the